Delivery Order SPE2DB22D1202-SPE2DB23FHZU9

Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $826.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 milliliter vials of Gadavist, a magnetic resonance contrast agent. Performance will take place in Conshohocken, Pennsylvania over a one-day period from August 1st to August 2nd, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $11,701 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 millimolar, 10 milliliter vials of Gadavist contrast agent. Performance will take place in Conshohocken, Pennsylvania over one day in early September 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the magnetic resonance imaging contrast media in support of the Defense Logistics Agency's medical material procurement programs. No...
The Defense Logistics Agency awarded a $1,183 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561357990 GADAVIST 10 MMOL/10 ML VIAL 10ML. The contract has a period of performance from June 27, 2023 through June 28, 2023 for place of performance in Conshohocken, Pennsylvania. Gadavist is a contrast agent used in magnetic resonance imaging exams to enhance visualization of blood vessels and organs. This delivery order was issued against an existing DLA pharmaceuticals...
The Defense Logistics Agency awarded a delivery order valued at approximately $719 to Amerisourcebergen Drug Corporation for Gadavist, a contrast agent used in magnetic resonance imaging. To be performed over a one day period in Conshohocken, Pennsylvania, the firm fixed price contract calls for the delivery of 10 millimoles of Gadavist in 10 milliliter vials. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,910 to Amerisourcebergen Drug Corporation to provide 30mL vials of Gadavist, a magnetic resonance contrast agent, for delivery by August 1, 2023. Amerisourcebergen will perform under the contract from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States military...
The Defense Logistics Agency awarded a $489.02 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561834814 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The place of performance is Conshohocken, Pennsylvania. The start date is August 16, 2023 and end date is August 17, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and distributing medical supplies to military treatment facilities worldwide. This delivery order for the contrast agent...
The Defense Logistics Agency Troop Support Medical awarded a $305.60 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 7.5 mmol/7.5 ml vials of Gadavist contrast agent. Place of performance will be in Conshohocken, Pennsylvania over a period of three days from August 11th through the 14th of 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp. No subcontractors or set aside designations were identified. This delivery...
This is a $2,912.40 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The order is for Gadavist, a contrast agent used in medical imaging procedures. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,258.75 contract is for the supply of Gadavist, a 10 mL vial of contrast agent used in medical imaging procedures. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00, which serves as the primary contract...
The Defense Logistics Agency awarded a delivery order valued at $3,045.09 to Amerisourcebergen Drug Corporation for 4561920232 GADAVIST 10 MMOL/10 ML VIAL 10ML. Performance will occur in Conshohocken, Pennsylvania under a firm fixed price arrangement from August 23 to August 24, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB23FHZU9
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at one thousand eight hundred fifty-one dollars and ten cents ($1,851.10) to Amerisourcebergen Drug Corporation for 4561977026 Gadavist 10 mmol/10 ml vials. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is for ten (10) milliliters of Gadavist contrast agent to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were indicated. Amerisourcebergen Corporation will perform as the prime contractor through August 30, 2023 to fulfill this requirement for magnetic resonance imaging contrast agents.

Generated 12/24/23, 12:59 AM